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The consequences of replacing CysoJ in the FrdB subunit of ~s&rfc& coli fumarate reductasc by Asp or Ala have been investigated in terms 
of bacterial Srowth, enzymatic activity, and the EPRIredox properties of the [2Fe-2S] cluster. An aspartic acid residue occupies the equivalent 
position in E. co/i succinate dehydrogenase, and the FrdBCys65Asp mutation has little effect on cell growth, enzyme activity or the physical 
propertics of the Frd [ZFe-2S] cluster. In contrast, the [ZFe-?S] cluster was not observed in the FrdBCy@Ala mutant showing that a coordinating 
residue is required at this position for assembly of this cluster and significant levels of enzymatic activity. These results support the presence of 
one non-cysteinyl, oxygenic ligand for the [2Fe-2s) cluster in E. coli succinatc dehydrogcnase. 
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1. INTRODUCTION 
Based on the available EPR and amino acid sequence 
data it is probable that all fumarate reductases and 
succinate dehydrogenases, irrespective of their animal 
or bacterial origin, contain three distinct types of Fe-S 
cluster: Center 1, a [2Fe-2S12+*’ cluster; Center 2, a [4Fe- 
4w+*+ cluster; Center 3, a [3Fe-4S]**’ cluster [i,2]. 
Recent electrochemical nd spectroscopic studies of 
mutant forms of the fumarate reductase from 
Escherichia coli in which individual cysteine residues 
were mutated to serines, provided the first definitive 
evidence that the four cysteinyl residues located near the 
N-terminus of FrdB subunit are involved in the ligation 
of Center 1 [3]. The arrangement and location of these 
four cysteinc residues are conserved in all iron-sulfur 
protein (Ip) subunits of fumarate reductases and suc- 
cinate dehydrogenases for which the sequences are 
known [3], with the notable exception of the succinate 
dehydrogenase from E. coli [4], which has an aspartic 
acid residue in place of the third cysteine (CYSTS in E. coIi 
fumarate reductase). However, this apparent difference 
in the ligation of Center 1 in E. coli succinate dehy- 
drogenase is not reflected in anomalous EPR or redox 
ADbreviurions: BVti, reduced benzyl viologcn; MQHz, menaquinol-6; 
PMS, phenazinc methosulfate. 
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properties for this cluster [5,6j. To assess further the 
importance of the nature of the residue at this position 
on the assembly and properties of Center 1 and the 
enzymatic activity, we have constructed and charac- 
terized E. co/i fumarate reductase mutants in which 
Cys6’ of Ip is replaced by Asp (FrdBCy@Asp mutant) 
or Ala (FrdBCys6’Ala mutant). The results are com- 
pared with those obtained for the wild-type and 
FrdBCys%er mutant [3]. 
2. MATERIALS AND METHODS 
The I!?. co/i strains used for growth and biochemical measurements 
have been described previously [7j. DW12 contains a deletion of the 
J-d operon (dfdABCD) and strain DW35 contains thcfid deletion as 
well as a disruption of the sa% operon (sdhC::kun). Both strains are 
devoid of fumarate reductase activity, and are incapable of growth on 
anaerobic glyceroUfumarate medium, unless they contain a plasmid 
encoding a functional fumarate reductase complex. Site-directed mu- 
tagen&s offidlB was performed as in previous work [3] with oligonu- 
cleotides designed to change Cys” of FrdB to either Ser. Asp or Ala. 
The mutations were confirmed by DNA sequence analysis of both the 
single~stranded phagc used for construction and the double-stranded 
DNA of the plasmid used for expression of the mutant protein [3]. 
Growth studies, the preparation of cytoplasmic membrane fractions, 
and the catalytic assays were carried out as previously described [3,7- 
91. 
EPR samples of cytoplasmic membrane preparations of E. coli 
DW12 or DW35 with plasmid-amplified expression of wild-type or 
mutant fumarate reductase were oxidized with 20 mM fumamte or 
reduced with 20 mM succinate or 10 mM dithionitc. Dye-me&ted 
EPR redox titrations were carried out as previously described [3]. 
Reduction potentials were measured at pH 7.0 with a platinum work- 
ing electrode and a AgIAgCl reference lectrode and are reported 
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relative to the normal hydrogen electrode. EPR spectra were recorded 
at X-band using an IBMlBruker ERlOOD spectrometer with data 
storage, and mxnipulation performed on an ESP ;600 data processing 
system. Sample temperatures in the range 4-80 K were obtained using 
an Oxford Instruments ESR-9 cryostat. 
3. RESULTS 
Growth data for E. coli DW35 with plasmid-ampli- 
fied expression of wild-type, as well as FrdBCy&er, 
FrdBC#‘Asp, and FrdBCysdSAia mutant fumarate 
reductases, plus the enzymatic activities for cytoplasmic 
membrane preparations are shown in Table I. Com- 
pared to the wild-type control, the FrdBCys%er and 
FrdCys65Asp mutations had no significant effect on the 
rate of cell growth under conditions requiring a func- 
tional fumarate reductase (i.e. anaerobic growth on gly- 
cerol/fumarate medium or aerobic growth on minimal 
succinate medium). In contrast, no growth was ob- 
served for the FrdBCy@‘Ala mutant under either condi- 
tions. With non-physiological electron donors and ac- 
ceptors, the FrdBCys%er and FrdBCysG5Asp mutants 
both had slightly impaired fumarate reductase and suc- 
cinate dehydrogenase activities compared to wild-type, 
i.e. -15% decrease in fumarate:BY,,d oxidoreductase ac- 
tivity and -50% decrease in succinate:PMS oxido- 
reductase activity. However, fumarate reductase activ- 
ity using the physiological electron donor, MQHzp was 
comparable to wild-type for the FrdBCy@Asp mutant, 
and significantly increased for the FrdBCys’%er 
mutant. In accord with the growth data, the 
FrdBCy@Ala mutation resulted in drastically reduced 
enzymatic activity in the MQH1-fumarate reductase 
assay and both of the non-physiological enzyme assays. 
The growth and activity data reported here for the 
FrdBCysb5Ser mutant relative to wild-type are in good 
agreement with previous data obtained with E. co/i 
DW12 (dfr&BCD) [3]. 
EPR spectra of fumarate-oxidized and dithionite-re- 
duced cytoplasmic membrane samples of E. cofi DW35 
with plasmid-amplified wild-type, FrdBCy@Ser, 
FrdBCy@Asp and FrdBCy@Ala fumarate reductases 
are shown in Fig. 1. Identical spectra were observed for 
samples prepared using either the DW12 or DW35 ,!Z, 
co/i strains. The presence of Center 3 in all three 
mutants is showI! by the observation of the characteris- 
tic EPR resonance of the S = l/2 [3Fe-4S]* cluster, g = 
2.016, -1.98, -1.93, in the fumarate-oxidized membranes 
[lo]. As predicted from the activity data, fumarate was 
noi effective in oxidizing the FrdBCy@‘Ala mutant and 
identical EPR spectra were observed for the membranes 
as prepared in the absence of fumarate. EPR signals 
indicative of a S = l/2 [2Fe-2S]’ cluster, Center 1, i.e. 
g, = 2.01-2.03, + = 1.92-l .93, g, = 1.92-l .93 and obser- 
vable without significant broadening at 70 K, are ob- 
served in the succinate- and dithionite-reduced samples 
of the FrdBCys%er and FrdBCys65Asp mutants, but 
not the FrdBCys65Ala mutant. The presence of the di- 
thionite-reducible S = l/2 [4Fe-4S’Jz’l+ cluster, Center 2, 
in E. cofi fumarate reductase can be assessed by dra- 
matic enhancement of the spin relaxation of Center 1 in 
dithionite- vs. succintite-ieduced samples, or by direct 
observation of a broad fast-relaxing resonance, with 
features to high- and low-field of ihe Center 1 reso- 
nance, at temperatures below 20 K in dithionite-reduced 
samples 111,121. Based on both criteria, Center 2, is 
present in both the FrdBCys”‘Ser and FrdBCys65Asp 
mutants. The enhancement in spin relaxation is shown 
by the more than loo-fold increase in the Center 1 half- 
saturation parameter, PL,2, that accompanies dithionite 
reduction (see Table 11). The dithionite reduced samples 
of these mutants also exhibited a broad resonance at 10 
K with features at g = 2.17, 2.06, 1.82 and 1.65 (data 
not shown), identical to that observed and attributed to 
reduced Center 2 in the wild-type membranes. However, 
no additional S = l/2 resonances, over and above those 
observed for the control samples of the fumarate reduc- 
tase deletion strains, DW12 and DW35, were observed 
in the dithionite-reduced samples of the FrdBCy$j5Ala 
mutant. Although this suggests that Center 2, in addi- 
tion to Center 1, is not assembled in the FrdBCysdSAla 
Table I 
Growth properties and enzyme activities for IZ. roll DW35 with plasmid-amplified xpression of wild-type and mutant 
fumarate rcductases 
- 
P&mid Doubling time (h) Turnover numb& (min-I) 
-0zb +o,c BV,,-fumarate MQH,-fumarate Succinate-PMS 
oxidoreductnse oxidorcductase oxidoreductase 
pH3 wild-type 2.2 2.1 30,200 18,700 10,400 
pH3 FrdBCys61Ser 2.5 2.9 26,500 27,300 5,600 
pH3 FrdBCys@Asp 2,6 2.4 25,000 17,600 4,500 
pH3 FrdBCys6’A!a n.g. n.g, 900 400 300 
“Tumovcr numbers based on 1 mol of histidyl-FAD per mol of enzyme for cytoplasmic mcmbrlrns frrciions. 
bAnacrobic growth on Slycerol/fumam:e medium. 
‘Aerobic growth on succinate minimal media, 
n.g., no growth. 
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Fig. I, X&anJ EPR spectra of fumarate-oxidized (left panel) and dithionite-reduced (right panel) cytoplasmic membrane preparations of E, CO/~ 
DW35 with plasmid-amplified expression of wildqpe and mutant forms of fiunaratc reductase. (a) Wild-type. (b) FrdBCys65Ser mutant. (c) 
FrdBCysbsAsp mutant. (d) FrdBCys65Ala mutant. The relative spectrometer gains are the same for each pair of fumarate-oxidized and dhhionitc- 
reduced samples. Conditions: temperature. 13 K; microwave power, 1 mW; modulation amplitude, I mT, frequency, 9.44 GHa. 
mutant, we cannot rule out the possibility that it is 
assembled as a [4Fe-4S’j cluster that is either no longer 
reducible by dithionite or is reduced but has a S = 312 
ground state. Broad EPR signals from S = 3/2 [4Fe_clS]+ 
Table II 
EPR properties and midpoint potentials of Center I in cytoplasmic 
membranes of E. cofi DWL? with plasmid-amplified wild-type and 
mutant fumaratc reductases 
.--__ 
Plasmid BPR g values Pm values” (mw) 
Succinate Dithionitc E,,,b (mv) 
pH3 wild-type 2.025, 1.930.1.920 0.30 100 -79’ 
pH3 Frd13Cys65Ser 2.013, 1.920, I .920 0.45 -49’ 
pH3 FrdBCysb5Asp 2.025, 1.930, I .930 0.25 ix -76 
pH3 FrdBCydSAla n.0. 
UHall’-saturation powers at IO 26. for succinate- and dithioniteqeduced 
samples. 
“pH 7.0 vs. standard hydrogen electrode. 
CTaken from [3]. 
n.o., not observed. 
b 
Fig. 2. EDR redo% titrations for Center 1 in cytoplasmic membrane 
preparations of E. coli DWl2 with plasmid-amplhied xpression of 
wild-type and mutant forms of furnarate reductase. The peak-to- 
trough EPR intensity at 35 K and I mW microwave power of the 
derivative-sbapcd fcaturc, cxntcrcd between g = 1.93 and 1.92, is 
plotted as a function of the potential measured relative to the normal 
hydrogen electrode. The solid liacs represent least-squares fits of the 
data to a one-electron Nernst equation. (0) Wild-type, Em = -79 mV; 
(a), FrdBCys%er mutant, Em = -49 mV, (A) FrdBCystiAsp mutant, 
Em-76 mV. 
3 
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clusters would be extremely difficult to detect in mem- 
brane samples. Further spectroscopic studies of the iso- 
lated tetrameric omplex are planned to evaluate these 
possibilities. 
As previously reported [3], the effect of the 
FrdBCy&j5Ser mutation on Center 1 is manifest by a 
small change in EPR g values and a 30 mV increase in 
mid-point potential compared to wild-type. In contrast, 
the FrdBCys65Asp mutation results in no significant 
change in mid-point potential of Center 1 and EPR g 
values that are almost identical to wild-type except for 
slightly less pronounced rhombic splitting on g, (see 
Table II and Figs. 1 and 2). We conclude that neither 
the fumarate reductase activity nor the properties of 
Center 1 are significantly perturbed by the 
FrdBCys65Asp mutation in E. cd’ fumarate reductase. 
4. DISCUSSION 
With the notable exception of the Rieske protein, 
X-ray crystallographic studies of electron transfer 
proteins containing [2Fe-2S], [3Fe-4S] and [4Fe-4S] 
centers have shown these clusters to be coordinated 
exclusively by cysteinyl S. However, in some bacterial 
ferredoxins, notably Desulfovibrio africanus FdIII [ 133 
and Pyrococcus furiosus Fd [IS], an aspartate residue is 
found in place of one of the conserved cysteine residues 
resulting in [4Fe-4S]?+b+ clusters with one non-cysteinyl 
l&and. The results presented here serve to demonstrate 
that one of the cysteines that is involved in ligating the 
[2Fe-2S] cluster in E. coli fumarate reductase can be 
replaced by aspartate without significant perturbation 
of the spectroscopic, catalytic or redox properties. 
Moreover, it is clear that Center 1 in E. co/i succinate 
dehydrogenase provides an in vivo example of a [2Fe- 
2S3 cluster with the same type of anomalous coordina- 
tion, i.e. one non-cysteinyl ligand. 
The absence of Center 1 in the FrdBCys65Ala mutant 
shows that a residue with potential for metal coordina- 
tion such as Cys, Ser or Asp is required at position 65 
for assembly of tr;e [2Fe-2S] cluster in E. co/i FrdB. 
Whether these residues coordinate directly to Fe or in- 
directly by hydrogen bonding to a coordinated water 
molecule remains to be established. The relatively minor 
changes in g value anisotropy and mid-point potential 
that accompany mutation of CysGs for Ser or Asp can 
be rationalized in terms of changes in coordination pro- 
vided it is occurring at the localized valence Fe(II1) site 
of the cluster. More dramatic changes would only be 
expected, and are observed, for mutations that perturb 
the ligand field on the localized valence Fe(II) site [3]. 
We have considered the possibility whereby aspartate 
coordination to Center 1 may be one of several factors 
that determine whether the enzyme functions as a fu- 
marate reductase or succinate dehydrogenase. This is 
unlikely for several reasons. First, all other succinate 
dehydrogenases that have been sequenced thus far have 
a conserved cysteine in the position analogous to Cys6’ 
in E. coli FrdB. Second, the FrdBCy@‘Asp mutant 
retained its native fumarate reductase activity while un- 
dergoing a 50% decrease in succinate dehydrogenase 
activity with PMS as the electron acceptor. Third, since 
the redox potential of Center 1 is unchanged in the 
FrdBCys?Asp mutant, it is unlikely that aspartate 
coordination alone can be invoked to explain the in- 
crease in the mid-point potential of this cluster in E. co/i 
succinate dehydrogenase compared to E. coii fumarate 
reductase. In general, Center 1 has a lower potential in 
fumarate reductases (Em = -20 mV to -SO mV) com- 
pared to succinate dehydrogenases ,$,, = -10 mV to +-SO 
mV), which is consistent with the opposite direction of 
electron flow [2]. However, the activity results for the 
FrdBCys”‘Ser mutant, in which the mid-point potential 
of Center 1 is increased by 30 mV, demonstrate that 
increasing the potential of Center 1 does not necessarily 
equate to enhanced succinate dehydrogenase activity. 
Acknowked~en~onrs: This work was supported by the Veterans Ad- 
ministration and grants from the National Science Foundation 
(DMB9104297 to G.C.) and the National Institutes of Health 
(HLlG251 to G.C. and R.P.G., and GM33806 to M.K.J.) and the 
Deutscbe Forschungsgemeinschaft (to IS.), WC thank Dr. Brian AC. 
Ackrell for many stimulating discussions. 
REFERENCES 
[I] Ohnishi, T. (1987) Curr. Top. Bioenerg. 15, 37-65. 
[2] Ackrell, B-AC., Johnson, M.K., Gunsalus, RP. and Cecchini, 
G. (1991) in: Chemistm and Biochemistry of Flavoenzymcs, vol. 
[31 
:; 
[6] 
171 
[81 
191 
IlO1 
llll 
1121 
[I31 
III (F. Mullet- ed.) pp. 229-297, CRC Press, Boca Raton, 
Werth, M.T., Cecchini, G., Manodori, A., Ackrell, B.A.C., 
Schrbder, I., Gunsalus, R.P. and Johnson, M.K, (1990) Proc. 
Natl. Acad. Sci. USA 87, 89658969. 
Darlison, M.G, and Guest, J.R. (1984) Biochem. J 223,507~517. 
Condon, C., Cammack, R., Patil, D.S. and Owen, P. (1985) J. 
Biol. Chem. 260,9427-9434. 
Kita, K., Vibat, C.R.T.. Meinhardt, S., Guest, J.R. and Gennis, 
R.B.(1989) J. Biol. Chcm. 264, 2672-2677. 
Schrllder, I., Gunsalus, R.P., Ackrell, B.A.C,, Cochran, 13. and 
Cecchini, G. (1991) J. Biol. Chem. 2GG, 13572-13579. 
Cecchini, G., Ackrcll, B.A.C., Deshlcr, J-0. and Gunsalus, R.P. 
(1986) J. Biol. Chem. 261, 1808-1814. 
Cccchini, G,, Thompson, CR., Ackrell, B.A.C., Westonberg, 
D.J., Dean, N. and Gunsalus, R.P. (1986) Proc. Nat]. Acad. Sci. 
USA 83, 8898-8902. 
Morningstar, J.E., Johnson, M.K., Cccchini, G., Ackrell, B.A.C. 
and Kenrney, E.B. (1985) J. Biol. Chem. 2G0, 13631-13638. 
Johnson, M,K., Morningstar, J.E., Cecchini, G. and Ackrell, 
B.A.C. (1985) Biochem. Biophys. Res. Commun. 131, 75G-762. 
Cammack, R., Patil, D.S. and Weiner, J.H. (1986) Biochim. 
Biophys. Acta 870, 545-551. 
George, S.J., Armstrong, F.A., Hatchikian, EC. and Thomson, 
A.J. (1989) Biochem. J. 264, 275-284. 
[14] Conovcr, R.C., Kowsl, A.T., Fu, W., Park, J.-B., Aono, S., 
Adams, M,W.W. and Johnson, M.K. (1990) J. Biol. Chem. 265, 
8533-8541. 
4 
